Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Radiat Res. 2019 Jul 11;192(3):267–281. doi: 10.1667/RR15379.1

FIG. 9.

FIG. 9.

Lack of additional radioresistance in JP4–039 or necrostatin-1 treated Serpinb3a−/− marrow stromal cells. Serpinb3a+/+ Balb/c (panel A) and Serpinb3a−/− (panel B) bone marrow stromal cell lines were treated with JP4–039 (10 mM) or necrostatin-1(10 mM) 1 h before irradiation, as described in the Materials and Methods, then plated for clonogenic survival curve assays, as described in the Materials and Methods.